NCT01753908View on ClinicalTrials.gov

Broccoli Sprout Extract in Treating Patients With Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 21, 2013

Primary Completion Date

July 23, 2018

Study Completion Date

August 23, 2018

Conditions

Ductal Breast CarcinomaDuctal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor PositiveInvasive Breast CarcinomaLobular Breast CarcinomaPostmenopausalStage IA Breast CancerStage IB Breast CancerStage IIA Breast CancerStage IIB Breast Cancer

Interventions

DRUG

Broccoli Sprout Extract

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Urinary ITCs and metabolites measured

OTHER

Placebo

Given PO

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT01753908 - Broccoli Sprout Extract in Treating Patients With Breast Cancer | Biotech Hunter | Biotech Hunter